SNSE
Sensei Biotherapeutics Inc
NASDAQ: SNSE · HEALTHCARE · BIOTECHNOLOGY
$20.73
+4.76% today
Updated 2026-06-04
Market cap
$15.31M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-142.72
Dividend yield
—
52W range
$6 – $37
Volume
0.0M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.5
Quality
B3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-16.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$51.67
+149.25%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -16.85 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-10.74M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-48.81M | $-34.10M | $-30.16M | $-21.09M | $-170.24M |
| EPS | — | — | — | — | $-142.72 |
| Free cash flow | $-39.35M | $-32.20M | $-24.82M | $-20.47M | $-10.74M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Sensei Biotherapeutics Inc trades at $20.73. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -16.85, it sits in the distress.
Frequently asked questions
What is Sensei Biotherapeutics Inc's stock price?
Sensei Biotherapeutics Inc (SNSE) trades at $20.73.
Is Sensei Biotherapeutics Inc overvalued?
Sensei Biotherapeutics Inc carries a Smart Value Score of 29/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Sensei Biotherapeutics Inc (SNSE)?
The 12-month analyst consensus target is $51.67, about 149.3% above the current $20.73. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Sensei Biotherapeutics Inc's Altman Z-Score is -16.85, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-74.00%
Beta-0.23
50D MA$24.23
200D MA$16.22
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—